CRIS Current Research Information System

PANE, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.693
NA - Nord America 1.349
EU - Europa 1.245
AF - Africa 77
SA - Sud America 70
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.437
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.326
VN - Vietnam 646
GB - Regno Unito 444
SG - Singapore 391
CN - Cina 324
SE - Svezia 166
IT - Italia 162
HK - Hong Kong 128
DE - Germania 109
FR - Francia 66
IN - India 65
BR - Brasile 50
CH - Svizzera 49
IE - Irlanda 49
RU - Federazione Russa 47
NL - Olanda 39
FI - Finlandia 26
JP - Giappone 24
JO - Giordania 22
TG - Togo 22
ZA - Sudafrica 22
BG - Bulgaria 21
EE - Estonia 19
CA - Canada 16
KR - Corea 16
CI - Costa d'Avorio 11
PL - Polonia 10
UA - Ucraina 10
AR - Argentina 9
PH - Filippine 9
BD - Bangladesh 8
NG - Nigeria 8
TR - Turchia 8
ID - Indonesia 7
MY - Malesia 7
TH - Thailandia 7
GR - Grecia 6
AT - Austria 5
IQ - Iraq 5
IR - Iran 5
MX - Messico 5
EC - Ecuador 4
UZ - Uzbekistan 4
BE - Belgio 3
CO - Colombia 3
ES - Italia 3
SA - Arabia Saudita 3
TN - Tunisia 3
TW - Taiwan 3
AU - Australia 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
IS - Islanda 2
MA - Marocco 2
PA - Panama 2
PK - Pakistan 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
CL - Cile 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GI - Gibilterra 1
HR - Croazia 1
IL - Israele 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
MC - Monaco 1
MW - Malawi 1
NO - Norvegia 1
NP - Nepal 1
PY - Paraguay 1
QA - Qatar 1
SC - Seychelles 1
UY - Uruguay 1
VE - Venezuela 1
Totale 4.437
Salva come PNG Salva come JPEG
Città #
Southend 422
Singapore 275
Chandler 173
Ho Chi Minh City 164
Ashburn 159
Hong Kong 119
Hanoi 118
Fairfield 100
San Jose 91
Dong Ket 86
Beijing 63
Houston 54
Woodbridge 51
Seattle 50
Santa Clara 49
Bern 48
Dublin 47
Princeton 45
Wilmington 37
Ann Arbor 28
Cambridge 27
Los Angeles 26
Boardman 25
Nanjing 23
Amman 22
Lauterbourg 22
Lomé 22
Bologna 21
Sofia 21
Tokyo 21
Hefei 20
New York 20
Westminster 20
Padova 19
Da Nang 18
Haiphong 17
Medford 17
Helsinki 16
Dallas 14
Milan 13
Buffalo 12
Abidjan 11
Seoul 11
Shenyang 11
Thái Nguyên 11
Ha Long 10
Turin 10
Jinan 9
Quận Bình Thạnh 9
Berlin 8
Biên Hòa 8
Can Tho 8
Guangzhou 8
Hangzhou 8
Hebei 8
Saint Petersburg 8
San Diego 8
São Paulo 8
Warsaw 8
Florence 7
Tianjin 7
Toronto 7
Vũng Tàu 7
Changsha 6
Des Moines 6
Falkenstein 6
Frankfurt am Main 6
Hải Dương 6
Redondo Beach 6
Torino 6
Abeokuta 5
Bắc Giang 5
Chicago 5
Jakarta 5
Lappeenranta 5
London 5
Ninh Bình 5
Orem 5
Quận Tân Phú 5
Redwood City 5
Rome 5
Turku 5
Bremen 4
Bắc Ninh 4
Chengdu 4
Council Bluffs 4
Mexico City 4
Munich 4
Nanchang 4
Phủ Lý 4
Shanghai 4
Tashkent 4
Tuy Hoa 4
Điện Bàn 4
Amsterdam 3
Ankara 3
Bangkok 3
Baoding 3
Brussels 3
Bình Phước 3
Totale 2.953
Salva come PNG Salva come JPEG
Nome #
Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia 385
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 279
The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) 209
BCR-ABL1 transcript detection in patients with Philadelphia-positive Acute Lymphoblastic Leukemia (ALL) using a new and high sensitive nanofluidic method 198
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib 194
The Bcr-Abl kinase promotes aberrant expression of spliced oncogenic Ikaros isoforms in Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL) patients treated with tyrosine kinase inhibitors 193
The 'Next-in-Cml' Study: A Prospective Multicenter Study of Deep Sequencing of the BCR-ABL1 Kinase Domain in Philadelphia Chromosome-Positive Patients with Non-Optimal Responses to Tyrosine Kinase Inhibitor Therapy 183
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 174
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia 173
TP53 Alterations Including Missense Mutations, Aberrant Exon-Junctions and Internal Intron Retentions Are Frequent and May Contribute to MDM2 Antagonist-Resistance in B-Acute Lymphoblastic leukemia 172
IKZF1 (IKAROS) Deletions Are Independent On BCR-ABL1 Rearrangement and Are Associated with a Peculiar Gene Expression Signature and Poor Prognosis in Adult B-Progenitor Acute Lymphoblastic Leukemia (ALL) Patients. 167
Can early switch to rituximab-bendamustine in a patient with follicular non-Hodgkin lymphoma progressing during R-CHOP be considered frontline treatment?: A case report 163
An Italian Multicentre Study Using Different Digital PCR Instruments on BCR-ABL1 Positive Patients at Different Levels of CML Disease 161
Down-Regulation of BMI-1 Is a New Marker of Sensitivity to Mdm2 Inhibition in B-Acute Lymphoblastic Leukemia. 159
Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study 150
Innovative phase I-II study of concomitant and consecutive treatment with Dasatinib and MK-0457 in refractory Ph+ CML and ALL patients 149
One-Step Quantitative Molecular Approach for Detection of BCR/ABL1 Rearrangement and for Monitoring of Minimal Residual Disease in CML Patients: An Inter Laboratory Study 148
Expression of different isoforms of the B-cell mutator activation-induced cytidine deaminase (AID) in BCR-ABL1-Positive Acute Lymphoblastic Leukemia (ALL) Patients 148
High-resolution genomic profiling of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) patients identified novel recurrent copy number variations involved in both pathogenesis and resistance to tyrosine kinase inhibitors 145
Evaluation of Cepheid Xpert® BCR-ABL Monitor Assay in Three Italian Reference Centers for Monitoring of BCR-ABL Transcript Levels in CML Patients 144
Genome wide analysis of Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) reveals a recurring deletion of VPREB1 gene which affects B-cell differentiation 137
High-resolution molecular allelokaryotyping identifies novel genomic alterations in acute promyelocytic leukemia (APL) 135
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis 129
Impact of calreticulin mutations on treatment and survival outcomes in myelofibrosis during ruxolitinib therapy 128
Molecular Characterization of PAX5 alterations in Adult BCR-ABL1-Positive Acute Lymphoblastic Leukemia (ALL) 114
null 91
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC) 83
A Real‐Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B‐Cell Lymphoma. 8
Totale 4.519
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.103
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021199 0 0 0 0 0 0 0 0 0 30 21 148
2021/2022503 34 21 40 39 53 27 8 26 21 51 92 91
2022/2023602 48 93 19 77 37 47 19 29 120 7 47 59
2023/2024129 8 29 10 7 4 40 5 5 7 4 1 9
2024/2025584 34 59 50 38 102 25 50 26 5 56 18 121
2025/20261.551 265 223 90 73 173 66 128 59 363 111 0 0
Totale 4.519